Skip to main content
. 2023 Jan 22;15(2):382. doi: 10.3390/pharmaceutics15020382

Figure 8.

Figure 8

FTIR spectra: (a) NiPMAm monomer, (b) NiPAm monomer, (c) crosslinker EGDM and (d) synthesized p(NiPMAm/NiPAm) copolymer with 2 mol% of EGDM.